Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load
Open Access
- 1 July 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 78 (1) , 69-72
- https://doi.org/10.1038/bjc.1998.444
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Regulation of p53 stability by Mdm2Nature, 1997
- Frequent Occurrence of p53 Gene Mutations in Uterine Cancers at Advanced Clinical Stage and with Aggressive Histological PhenotypesJapanese Journal of Cancer Research, 1992
- Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.1992
- Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridizationVirology, 1992
- The status of the p53 gene in human papilloma virus positive or negative cervical carcinoma cell linesCarcinogenesis: Integrative Cancer Research, 1992
- Inherited p53 gene mutations in breast cancer.1992
- Papillomaviruses, p53, and cervical cancerThe Lancet, 1992
- The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.Proceedings of the National Academy of Sciences, 1991
- Detection of genital papillomavirus types by polymerase chain reaction using common primersAPMIS, 1991
- The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53Published by Elsevier ,1990